Labcorp Holdings Inc.

Labcorp Holdings Inc., commonly known as Labcorp, is a global life sciences company headquartered in Burlington, North Carolina, U.S. The company's core business revolves around providing innovative and comprehensive laboratory services for diagnosis, healthcare decisions, and drug development. Its mission is "to improve health and improve lives" by delivering vital insights and advancing science.

Labcorp operates through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. The Diagnostics Laboratories segment offers a wide array of clinical laboratory testing, encompassing routine and specialty tests such as oncology, HIV, DNA, environmental, wellness, toxicology, pain management, genetic testing, women's health, neurology, and autoimmune disease diagnostics, supported by an extensive network of patient service centers. The Biopharma Laboratory Services segment provides drug development, medical device, and diagnostic development services to pharmaceutical, biotechnology, medical device, and diagnostic companies, including preclinical research, clinical trial management, and central laboratory functions.

Adam H. Schechter serves as the Chairman, President, and CEO of Labcorp. Labcorp maintains a significant market presence as one of the largest clinical laboratory networks globally, operating in over 100 countries with a primary focus on the U.S. The company holds a leading position in the diagnostics industry, with over 27% market share, and is recognized as one of the nation's two largest independent clinical laboratories. In the first quarter of 2026, Labcorp announced strong results, raising its full-year guidance and highlighting recent innovations such as the launch of an FDA-approved companion diagnostic for ovarian cancer, an FDA-cleared Fentanyl Visual Urine Test, and an AI-powered real-world data platform developed with AWS and Datavant to accelerate Alzheimer's research. The company also introduced MyLabcorp, an AI-powered mobile app designed to provide individuals with test results and clinical guidance.